CB2 receptor levels are elevated in postmortem HD brains and mice models [119, 120], and treatment of the R6/2 HD mouse model with a CB2 receptor agonist suppresses neurodegeneration by regulating the IL-6 level in the blood [120]. Here, IL6 is linked to Huntington disease.